SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: Hank who wrote (2894)3/21/1998 3:42:00 PM
From: Dauntless  Respond to of 7041
 
OK, now we're both capable of errors (g)

Yes, not all drugs get approved, but FDA's own statistics admit 70-80 of drugs with completed phase III's & NDA's filed get approved.

I agree that a "small Biotech that is desperately in need of cash" could try & pull a fast one - but Zoangen had a phenomenally successful secondary offering & had over $70 million cash in bank at the time of the SGP deal.

I guess we'll just have to wait & see.